Research suggests that compounds derived from Pau d'Arco, particularly from plants in the Tabebuia genus, may influence immune function through several mechanisms, though the evidence base is limited and preliminary. The available studies include animal research showing that beta-lapachone reduced inflammation and improved survival in a mouse model of sepsis, and laboratory work demonstrating that water-based extracts of Tabebuia avellanedae suppressed T-cell proliferation through a mechanism distinct from beta-lapachone itself, pointing to potentially complex and mixed immunomodulatory effects. Additional studies touched on antivenom properties of Tabebuia rosea extracts and a general reference to herbal use in vaginal infections, though the latter lacked sufficient detail for meaningful interpretation. Taken together, the research is largely preclinical, consisting of animal and cell-based studies rather than human clinical trials, which means conclusions about immune-related effects in people cannot yet be drawn and the findings should be interpreted with caution.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| β-Lapachone Increases Survival of Septic Mice by Regulating Inflammatory and ... | Other | 2020 | Supports | 72 |
| [Natural remedies for vaginal infections]. | Other | 1995 | — | 67 |
| Snakebites and ethnobotany in the northwest region of Colombia: Part II: neut... | Other | 2000 | Neutral | 62 |
| Tabebuia avellanedae extracts inhibit IL-2-independent T-lymphocyte activatio... | Other | 2008 | Mixed | 57 |